# Maternal DHA Supplementation and Offspring Neurodevelopment in India (DHANI-2)

> **NCT03072277** · PHASE3 · COMPLETED · sponsor: **Public Health Foundation of India** · enrollment: 957 (actual)

## Conditions studied

- Pregnancy

## Interventions

- **DIETARY_SUPPLEMENT:** Docosa Hexaenoic Acid (DHA)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03072277
- **Lead sponsor:** Public Health Foundation of India
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2019-04
- **Final completion:** 2020-12
- **Target enrollment:** 957 (ACTUAL)
- **Last updated:** 2021-03-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03072277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03072277, "Maternal DHA Supplementation and Offspring Neurodevelopment in India (DHANI-2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03072277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*